All Resources

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more|View

April 28, 2022

Reflections on a Potential Pan-Canadian Drug Formulary: Medicines Industry Response to CADTH Consultation

Learn more|View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more|View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more|View

November 25, 2021

Innovative Agreements Framework Industry Oct 2021

Learn more|View

September 27, 2021

Note for Guidance on Virtual Interactions With Healthcare Professionals

Learn more|View

Access to Medicine • August 06, 2021

2022 Federal Pre-Budget Consultation

Learn more|View

Private Drug Coverage • August 01, 2021

Cost Drivers: Analysis of Private Drug Plans in Canada 2021

Learn more|View

Patented Medicine Prices Review Board (PMPRB) • June 21, 2021

Proposed Guidelines Monitoring and Evaluation Plan

Learn more|View

Economic Impact • June 03, 2021

Industry Fact Check

Learn facts and myths about the price of medicines, healthcare cost drivers and the economic contribution of industry….

Learn more|View

Vaccine Equity • April 30, 2021

Standing Committee on International Trade (CIIT) study of Canada’s International Trade and Investment Policy

Learn more|View

Access to Medicine • March 31, 2021

Making Canada an International Life Sciences Leader

Learn more|View